Sorrento Therapeutics Inc (NASDAQ:SRNE)
| 1.57 Delayed Data As of Sep 30 |  -0.015 / -0.95%Today’s Change | 1.15 Today|||52-Week Range 7.74 | -66.34% Year-to-Date |
Latest SRNE News | Press Releases
| Morphic Holding, Inc. (MORF) Moves 7.3% Higher: Will This Strength Last? Sep 29 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 1.58 |
| Today’s open | 1.55 |
| Day’s range | 1.55 - 1.66 |
| Volume | 153,108 |
| Average volume (3 months) | 9,689,576 |
| Market cap | $697.4M |
Data as of 4:02pm ET, 09/30/2022
Growth & Valuation
| Earnings growth (last year) | -11.89% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | +1.00% |
| Revenue growth (last year) | +32.31% |
| P/E ratio | NM |
| Price/Sales | 25.91 |
| Price/Book | 6.19 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| RAPTRapt Therapeutics In... | +0.26 | +1.09% |
| ANABAnaptysBio Inc | -0.55 | -2.11% |
| BCYCBicycle Therapeutics... | -0.44 | -1.85% |
| MORMorphoSys AG | -0.38 | -7.04% |
Data as of 4:02pm ET, 09/30/2022
Financials
| Next reporting date | November 3, 2022 |
| EPS forecast (this quarter) | -$0.25 |
| Annual revenue (last year) | $52.9M |
| Annual profit (last year) | -$428.3M |
| Net profit margin | -809.63% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters San Diego, California |
Forecasts
